There are many cancers that exhibit high angiogenesis activity either through overexpressing VEGF or its receptors or downstream effectors in the VEGF/VEGF receptor pathway, as in breast cancer [148], invasive bladder cancer [149], colon cancer, [150] and melanoma [151]. The gene discussed is VEGFA; the disease is breast cancer.